This invention relates to novel compounds of the Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals.
本发明涉及公式(I)的新化合物及其药学上可接受的盐,以及这些化合物的药物组合物,用于治疗与哺乳动物中11β-H
SD1的调节或抑制有关的疾病。